May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Serum Lipid Levels and Diabetic Retinopathy in Type 1 Diabetes Mellitus
Author Affiliations & Notes
  • B.M. Miljanovic
    Division of Preventive Medicine, Brigham & Women's Hospital/Harvard Medical School, Boston, MA, United States
  • R.J. Glynn
    Division of Preventive Medicine, Brigham & Women's Hospital/Harvard Medical School, Boston, MA, United States
  • D.M. Nathan
    Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States
  • J.E. Manson
    Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States
  • D.A. Schaumberg
    Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States
  • Footnotes
    Commercial Relationships  B.M. Miljanovic, None; R.J. Glynn, None; D.M. Nathan, None; J.E. Manson, None; D.A. Schaumberg, None.
  • Footnotes
    Support  Harvard Medical School Scholars in Medicine Award
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3099. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B.M. Miljanovic, R.J. Glynn, D.M. Nathan, J.E. Manson, D.A. Schaumberg; Serum Lipid Levels and Diabetic Retinopathy in Type 1 Diabetes Mellitus . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3099.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Current research results are inconsistent as to whether lipids are associated with the development of diabetic retinopathy (DR). We evaluated the relationship between serum lipid levels and DR in a large population with type 1 diabetes mellitus (DM). Methods: We studied the 1441 subjects participating in the Diabetes Control and Complications Trial (DCCT). Serum lipids (total cholesterol, LDL, HDL, total/HDL ratio, and trigycerides) were measured at baseline and then updated annually. We used Cox proportional hazards regression models with time-varying covariates to examine the relationship of the most recent lipid levels with progression of DR as well as development of hard exudate (HE) and clinically significant macular edema (CSME). Results: In models controlling for baseline DR level and treatment group, there were significant associations of total/HDL ratio (RR=2.60 for top versus bottom quintile, trend p-value <0.01) and triglycerides (RR=2.40, trend p-value <0.001) with progression of DR, but the magnitude and significance of these associations decreased with the addition of hemoglobin A1c (HbA1c) to the model (each p-value >0.1). However, in multivariate models adjusting for baseline DR level, treatment group, age, gender, HbA1c, smoking status, and duration of diabetes total/HDL ratio was a significant predictor of CSME (RR=3.89, trend p-value =0.03) and HE (RR= 2.71, trend p-value <0.001); and LDL was also associated with both CSME (RR=1.54, trend p-value =0.03) and HE (RR=1.88, trend p-value <0.001). Conclusions: The findings that elevated serum lipids are associated with increased risk of CSME and retinal HE but not independently with progression of DR suggest a relationship with breakdown of the blood-retinal barrier. Aggressive treatment of elevated lipids among diabetic subjects to prevent cardiovascular disease may also decrease risk of CSME and retinal HE, particularly if a reduction in total/HDL ratio can be achieved.

Keywords: clinical (human) or epidemiologic studies: ris • diabetic retinopathy • lipids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×